Online inquiry

IVTScrip™ mRNA-Human ARID2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK25623MR)

This product GTTS-WK25623MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ARID2 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001347839.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 196528
UniProt ID Q68CP9
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARID2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK25623MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK24984MR IVTScrip™ mRNA-Human ARHGAP17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP17
GTTS-WK22040MR IVTScrip™ mRNA-Human ARL3, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL3
GTTS-WK25291MR IVTScrip™ mRNA-Human ARHGAP26, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP26
GTTS-WK10187MR IVTScrip™ mRNA-Human AFTPH, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA AFTPH
GTTS-WK10462MR IVTScrip™ mRNA-Human ADORA3, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADORA3
GTTS-WK8563MR IVTScrip™ mRNA-Human ACTL6A, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACTL6A
GTTS-WK14941MR IVTScrip™ mRNA-Human ANKUB1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKUB1
GTTS-WK23248MR IVTScrip™ mRNA-Human ARL6IP4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL6IP4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →